These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 876274)
1. Metabolic effects of somatostatin in maturity-onset diabetes. Tamborlane WV; Sherwin RS; Hendler R; Felig P N Engl J Med; 1977 Jul; 297(4):181-3. PubMed ID: 876274 [TBL] [Abstract][Full Text] [Related]
2. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717 [TBL] [Abstract][Full Text] [Related]
3. Effect of ketone infusions on amino acid and nitrogen metabolism in man. Sherwin RS; Hendler RG; Felig P J Clin Invest; 1975 Jun; 55(6):1382-90. PubMed ID: 1133179 [TBL] [Abstract][Full Text] [Related]
4. Effect of ketone bodies on glucose production and utilization in the miniature pig. Müller MJ; Paschen U; Seitz HJ J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544 [TBL] [Abstract][Full Text] [Related]
5. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. Saccà L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
6. Biphasic effect of somatostatin on oral glucose tolerance in maturity-onset diabetes. Tamborlane WV; Sherwin RS; Hendler R; Felig P Metabolism; 1978 Jul; 27(7):849-53. PubMed ID: 661568 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. Campbell PJ; Bolli GB; Cryer PE; Gerich JE N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524 [TBL] [Abstract][Full Text] [Related]
8. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Rizza RA; Cryer PE; Gerich JE J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413 [TBL] [Abstract][Full Text] [Related]
9. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans. Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277 [TBL] [Abstract][Full Text] [Related]
10. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. DeFronzo R; Deibert D; Hendler R; Felig P; Soman V J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552 [TBL] [Abstract][Full Text] [Related]
11. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics. Waldhäusl W; Bratusch-Marrain P; Nowotny P Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100 [TBL] [Abstract][Full Text] [Related]
12. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin. Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686 [TBL] [Abstract][Full Text] [Related]
13. Influence of glucagon replacement on the hyperglycemic and hyperketonemic response to prolonged somatostatin infusion in normal man. Sherwin RS; Tamborlane W; Hendler R; Saccá L; DeFronzo RA; Felig P J Clin Endocrinol Metab; 1977 Nov; 45(5):1104-7. PubMed ID: 925134 [TBL] [Abstract][Full Text] [Related]
15. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics. Villaume C; Beck B; Kolopp M; Toussain P; Debry G Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745 [TBL] [Abstract][Full Text] [Related]
16. Antidiabetic action of somatostatin after oral glucose loading: due to suppression of glucagon and growth hormone or of intestinal carbohydrate absorption? Bratusch-Marrain P; Vierhapper H; Grubeck-Loebenstein B; Waldhäusl W; Nowotny P Horm Metab Res; 1981 Jun; 13(6):305-9. PubMed ID: 6114914 [TBL] [Abstract][Full Text] [Related]
18. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)]. Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923 [TBL] [Abstract][Full Text] [Related]
19. Role of gluconeogenesis from amino acids in determining fasting and absorptive levels of plasma ammonia in cirrhosis. Trevisani F; Bernardi M; Grilli F; De Palma R; Piazzi S; Patrono D; Gasbarrini G Am J Gastroenterol; 1988 Jun; 83(6):646-51. PubMed ID: 2897785 [TBL] [Abstract][Full Text] [Related]
20. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics. Raskin P; Fujita Y; Unger RH J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]